Chris Blanchette

Adjunct Faculty
Vice President, Clinical Development & Outcomes Research, Novo Nordisk

Education: Ph.D. in Pharmaceutical Health Services Research, University of Maryland

Courses Taught: Healthcare Data Analysis HCIP 6102, Business Intelligence in Healthcare HCIP 6396, Problem Solving in Healthcare Analytics HCIP 6250


Dr. Blanchette is a clinical epidemiologist and health services researcher with over 20 years of experience as a professor, consultant and industry scientist leading research teams in the identification and measurement of chronic diseases and the evaluation of pharmaceutical treatment and healthcare services on clinical, economic and humanistic outcomes.
Specifically his expertise is in:
  • clinical research/experimental epidemiology
  • real world evidence (RWE)/ observational epidemiology
  • health economics and outcomes research (HEOR)
  • data science/analytics of real world clinical data (RWD)
In his current role, he leads the Clinical Development and Outcomes Research department at Novo Nordisk in the US which includes over 50 physician-scientists, epidemiologists, health economists, public health scientists and health services researchers working across Clinical Development, Health Economics and Outcomes Research (HEOR), Real World Evidence (RWE) and Evidence Synthesis and Value Assessment teams to develop clinical and real world evidence on the use of their products. In addition to his full time position Dr. Blanchette is also an Adjunct Professor with Saint Joseph's University Erivan Haub School of Business, the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, the Ernest Mario School of Pharmacy at Rutgers University and an Associate Graduate Faculty member for the School of Data Science at UNC Charlotte.